Page 7 - Daniel Drucker News Today

Every so often a drug comes along that has the potential to change the world. Medical specialists say the latest to offer that possibility are the new drugs that treat

The empty auditoriums, Gila monsters, resistant pharmaceutical executives and enigmas that led to Ozempic and other drugs that may change how society thinks about obesity.

While other drugs discovered in recent decades for diseases like cancer, heart disease and Alzheimer’s were found through a logical process that led to clear targets for drug designers, the path that led to the obesity drugs was not like that. In fact, much about the drugs remains shrouded in mystery.

Every so often a drug comes along that has the potential to change the world. Medical specialists say the latest to offer that possibility are the new drugs that treat obesity — Ozempic, Wegovy, Mounjaro and more that may soon be coming onto the market. It’s early, but nothing like these drugs has existed before. “Game changers,” said Jonathan Engel, a historian of medicine and health care policy at Baruch College in New York. Sign up for The Morning newsletter from t...

NY Times: Drug makers 'got lucky', experts say - and there's still a lot they don't know.

Scientists said it was not clear precisely how the drug cut people’s risk of heart complications.

From how well they work to side effects such as hair loss, here’s the skinny on new weight loss injections that work by blocking a hormone that normally reduces appetite

Hormone mimics offer advantages even beyond those of the potent weight-loss shots on the market now

Hormone mimics offer advantages even beyond those of the potent weight-loss shots on the market now

In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.